Interleukin-6 as a therapeutic target in spondylarthritis: Comment on the article by Tanaka et al

Arthritis Care and Research

Volumn 62, Issue 5, 2010, Pages 745-

  Wendling, Daniel ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; HLA B27 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; METHOTREXATE; SALAZOSULFAPYRIDINE; TOCILIZUMAB;

ARTHRITIS; DISEASE RESISTANCE; ERYTHROCYTE SEDIMENTATION RATE; GENETIC POLYMORPHISM; HUMAN; LETTER; PROMOTER REGION; PROTEIN TARGETING; REMISSION; SPONDYLARTHRITIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; HUMANS; INTERLEUKIN-6; SPONDYLARTHRITIS;

EID: 77951760151     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20086     Document Type: Letter

References (10)

1. Tanaka T, Kuwahara Y, Shima Y, Hirano T, Kawai M, Ogawa M, et al. Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab. Arthritis Rheum 2009;61:1762-1764
2. Wendling D, Racadot E, Toussirot E, Wijdenes J. Combination therapy of anti-CD4 and anti-IL6 monoclonal antibodies in a case of severe spondylarthropathy [abstract]. Br J Rheumatol 1996;35:1330. (Pubitemid 27032963)
3. Bal A, Unlu E, Bahar G, Aydog E, Eksioglu E, Yorgancioglu R. Comparison of serum IL-1 β, sIL-2R, IL-6, and TNF-α levels with disease activity parameters in ankylosing spondylitis. Clin Rheumatol 2007;26:211-215 (Pubitemid 46020247)
4. Gratacos J, Collado A, Filella X, Sanmarti R, Canete J, Llena J, et al. Serum cytokines (IL-6, TNF-α, IL-1 β and IFN-γ) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 1994; 33:927-931 (Pubitemid 24324807)
5. Park MC, Lee SW, Choi ST, Park YB, Lee SK. Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis. Scand J Rheumatol 2007;36:101-106 (Pubitemid 46685770)
6. Wendling D, Racadot E, Auge B, Toussirot E. Soluble intercellular adhesion molecule 1 in spondylarthropathies. Clin Rheumatol 1998;17:202-204 (Pubitemid 28346368)
7. Francois RJ, Neure L, Sieper J, Braun J. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor α in two patients with early disease and transforming growth factor β in three more advanced cases. Ann Rheum Dis 2006;65: 713-720 (Pubitemid 43799168)
8. Wendling D. Interleukin 23: a key cytokine in chronic inflammatory disease. Joint Bone Spine 2008;75:517-519
9. Jandus C, Bioley G, Rivals JP, Dudler J, Speiser D, Romero P. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum 2008;58:2307-2317
10. Collado-Escobar MD, Nieto A, Mataran L, Raya E, Martin J. Interleukin 6 gene promoter polymorphism is not associated with ankylosing spondylitis. J Rheumatol 2000;27: 1461-1463 (Pubitemid 30354045)